Our latest news

Synergie entre deux médicaments contre la leucémie myéloïde aigüe: à un pas d’un traitement efficace

Synergie entre deux médicaments contre la leucémie myéloïde aigüe: à un pas d’un traitement efficace

En combinant deux thérapies disponibles dans le commerce, les chercheurs du LBMCC/SNU ont observé une amélioration spec...
964 0
Drug synergy: one step closer to effective treatment of acute myeloid leukemia

Drug synergy: one step closer to effective treatment of acute myeloid leukemia

By combing two pre-existing therapies, researchers at the LBMCC/SNU dramatically increased their efficiency against leukemia...
1109 0
In cancer and aging, interconnected roles for apoptosis and cellular senescence

In cancer and aging, interconnected roles for apoptosis and cellular senescence

Researchers at the LBMCC review how these protective processes interact in cells' response to damage

A common feature of cancer and aging is cells' reduced ability to respond to stress-induced damage to DNA or cellular structu...
1079 0
Steps Toward Non-Toxic Cancer Therapy, with Help From the Sea

Steps Toward Non-Toxic Cancer Therapy, with Help From the Sea

A marine sponge could provide a new tumor-blocking drug and synergies with other therapies, Luxembourg researchers find.

Plants aren’t the only natural sources of potential new cancer treatments: a sea sponge has inspired the LBMCC lab’s latest a...

Related Publication

5910 0
Vers une thérapie non toxique contre le cancer, grâce à la mer

Related Publication

2552 0
Reining in Aggressive Prostate Cancer: Nature Provides Two Promising Inhibitors
2144 0
De la nature au chevet du patient : des molécules naturelles prometteuses contre le cancer de la prostate agressif
1802 0
Avancées en Neuro-Oncologie : Vaincre la résistance aux traitements chez les enfants atteints du neuroblastome
3564 0
Overcoming Drug Resistance in Childhood Neuroblastoma: Progress in Neuro-Oncology

Overcoming Drug Resistance in Childhood Neuroblastoma: Progress in Neuro-Oncology

A new study from Luxembourg could one day lead to personalized treatments for neuroblastoma, a notoriously drug-resistant form of cancer.

New findings from Luxembourg cancer lab LBMCC have the potential to help young children afflicted with a deadly form of cance...
4324 0